161 related articles for article (PubMed ID: 36436571)
1. The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease.
Goyal A; Agrawal A; Verma A; Dubey N
Exp Mol Pathol; 2023 Feb; 129():104846. PubMed ID: 36436571
[TBL] [Abstract][Full Text] [Related]
2. PI3K/AKT signaling mediated by G protein‑coupled receptors is involved in neurodegenerative Parkinson's disease (Review).
Nakano N; Matsuda S; Ichimura M; Minami A; Ogino M; Murai T; Kitagishi Y
Int J Mol Med; 2017 Feb; 39(2):253-260. PubMed ID: 28000847
[TBL] [Abstract][Full Text] [Related]
3. PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease.
Long HZ; Cheng Y; Zhou ZW; Luo HY; Wen DD; Gao LC
Front Pharmacol; 2021; 12():648636. PubMed ID: 33935751
[TBL] [Abstract][Full Text] [Related]
4. Curcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathways.
Jin T; Zhang Y; Botchway BOA; Zhang J; Fan R; Zhang Y; Liu X
Food Chem Toxicol; 2022 Jun; 164():113091. PubMed ID: 35526734
[TBL] [Abstract][Full Text] [Related]
5. Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.
Chen L; Cheng L; Wei X; Yuan Z; Wu Y; Wang S; Ren Z; Liu X; Liu H
Neurochem Res; 2017 Apr; 42(4):1141-1150. PubMed ID: 28005221
[TBL] [Abstract][Full Text] [Related]
6. Activation of Sonic hedgehog signal by Purmorphamine, in a mouse model of Parkinson's disease, protects dopaminergic neurons and attenuates inflammatory response by mediating PI3K/AKt signaling pathway.
Shao S; Wang GL; Raymond C; Deng XH; Zhu XL; Wang D; Hong LP
Mol Med Rep; 2017 Aug; 16(2):1269-1277. PubMed ID: 28627590
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway.
Huang N; Zhang Y; Chen M; Jin H; Nie J; Luo Y; Zhou S; Shi J; Jin F
Exp Gerontol; 2019 Sep; 124():110653. PubMed ID: 31295526
[TBL] [Abstract][Full Text] [Related]
8. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
10. Repurposing artemisinins as neuroprotective agents: a focus on the PI3k/Akt signalling pathway.
Arthur R; Navik U; Kumar P
Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):593-605. PubMed ID: 36464748
[TBL] [Abstract][Full Text] [Related]
11. Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway.
Liu Y; Geng L; Zhang J; Wang J; Zhang Q; Duan D; Zhang Q
Mar Drugs; 2018 Mar; 16(3):. PubMed ID: 29509717
[TBL] [Abstract][Full Text] [Related]
12. Wuzi Yanzong pill attenuates MPTP-induced Parkinson's Disease via PI3K/Akt signaling pathway.
Hang W; Fan HJ; Li YR; Xiao Q; Jia L; Song LJ; Gao Y; Jin XM; Xiao BG; Yu JZ; Ma CG; Chai Z
Metab Brain Dis; 2022 Jun; 37(5):1435-1450. PubMed ID: 35488941
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease.
Qin X; Zhang X; Li P; Wang M; Yan L; Pan P; Zhang H; Hong X; Liu M; Bao Z
J Drug Target; 2021 Sep; 29(8):875-883. PubMed ID: 33560148
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway.
Cai L; Tu L; Li T; Yang X; Ren Y; Gu R; Zhang Q; Yao H; Qu X; Wang Q; Tian J
Int Immunopharmacol; 2019 Oct; 75():105734. PubMed ID: 31301558
[TBL] [Abstract][Full Text] [Related]
15. Nootkatone alleviates rotenone-induced Parkinson's disease symptoms through activation of the PI3K/Akt signaling pathway.
Yao Z; Li J; Bian L; Li Q; Wang X; Yang X; Wei X; Wan G; Wang Y; Shi J; Guo J
Phytother Res; 2022 Nov; 36(11):4183-4200. PubMed ID: 35833337
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophic effects of a cyanine dye via the PI3K-Akt pathway: attenuation of motor discoordination and neurodegeneration in an ataxic animal model.
Ohta H; Arai S; Akita K; Ohta T; Fukuda S
PLoS One; 2011 Feb; 6(2):e17137. PubMed ID: 21347252
[TBL] [Abstract][Full Text] [Related]
17. Sulfated Hetero-Polysaccharides Protect SH-SY5Y Cells from H₂O₂-Induced Apoptosis by Affecting the PI3K/Akt Signaling Pathway.
Wang J; Liu H; Zhang X; Li X; Geng L; Zhang H; Zhang Q
Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28383489
[TBL] [Abstract][Full Text] [Related]
18. Human Basic Fibroblast Growth Factor Inhibits Tau Phosphorylation via the PI3K/Akt-GSK3β Signaling Pathway in a 6-Hydroxydopamine-Induced Model of Parkinson's Disease.
Yang PH; Zhu JX; Huang YD; Zhang XY; Lei P; Bush AI; Xiang Q; Su ZJ; Zhang QH
Neurodegener Dis; 2016; 16(5-6):357-69. PubMed ID: 27228974
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral Vector-Mediated SHC3 Silencing Exacerbates Oxidative Stress Injury in Nigral Dopamine Neurons by Regulating the PI3K-AKT-FoxO Signaling Pathway in Rats with Parkinson's Disease.
Gong J; Zhang L; Zhang Q; Li X; Xia XJ; Liu YY; Yang QS
Cell Physiol Biochem; 2018; 49(3):971-984. PubMed ID: 30184529
[TBL] [Abstract][Full Text] [Related]
20. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
